Key Events This Week
Apr 20: Stock opens week at Rs.995.90, down 0.48%
Apr 21: Modest recovery to Rs.997.65 (+0.18%)
Apr 22: Crosses Rs.1,000 mark, closing at Rs.1,001.80 (+0.42%)
Apr 23: New 52-week high at Rs.1,068.7 with 7.51% surge
Apr 24: Hits fresh 52-week high of Rs.1,084.4, closes slightly lower at Rs.1,068.05 (-0.27%)
Monday, 20 April 2026: Week Opens with Slight Decline
Strides Pharma Science Ltd began the week at Rs.995.90, down 0.48% from the previous Friday’s close of Rs.1,000.70. The stock traded on relatively low volume of 9,108 shares, mirroring the Sensex’s marginal decline of 0.02% to 35,814.68. This cautious start reflected broader market uncertainty, with the benchmark index showing minimal movement.
Tuesday, 21 April 2026: Modest Recovery Amid Market Strength
The stock edged up 0.18% to close at Rs.997.65 on lighter volume of 5,824 shares. This modest gain came alongside a robust Sensex rally of 0.77%, which closed at 36,091.30. Despite the broader market strength, Strides Pharma’s limited upside suggested investors were awaiting clearer catalysts for a sustained move.
Wednesday, 22 April 2026: Crossing the Rs.1,000 Threshold
Strides Pharma Science Ltd crossed the psychologically important Rs.1,000 mark, closing at Rs.1,001.80, a 0.42% increase. The stock traded 5,469 shares, while the Sensex slipped 0.23% to 36,009.59. This day marked the beginning of a positive price momentum that would accelerate in the following sessions.
Quarter after quarter, this Small Cap from the Lifestyle sector delivers without fail! Just added to our Reliable Performers with proven staying power. Stability meets growth here beautifully.
- - Consistent quarterly delivery
- - Proven staying power
- - Stability with growth
Thursday, 23 April 2026: Breakout with New 52-Week High and Strong Intraday Gains
Strides Pharma Science Ltd delivered a standout performance on 23 April, surging 6.90% to close at Rs.1,070.90 on heavy volume of 27,020 shares. The stock hit an intraday high of Rs.1,068.7, marking a new 52-week peak and a 7.51% intraday gain. This rally significantly outpaced the Sensex, which declined 0.78% to 35,729.71, and the Pharmaceuticals & Biotechnology sector, with Strides outperforming by 4.97% on the day.
The stock’s technical positioning was notably strong, trading above all key moving averages (5-day through 200-day), signalling sustained buying interest. Weekly indicators such as MACD and KST were bullish, while monthly signals showed mild caution but overall positive momentum. This breakout reflected growing investor confidence and momentum accumulation, supported by an upgrade in the Mojo Grade from Sell to Hold earlier in April and inclusion in the MomentumNow thematic list.
Friday, 24 April 2026: New 52-Week High Followed by Minor Pullback
On the final trading day of the week, Strides Pharma Science Ltd reached a fresh 52-week high of Rs.1,084.4, representing a remarkable gain of approximately 75.8% from its 52-week low of Rs.616.45. Despite this milestone, the stock closed slightly lower at Rs.1,068.05, down 0.27% on volume of 14,863 shares. The Sensex continued its downward trend, falling 1.06% to 35,349.66.
Technical indicators remained predominantly bullish on weekly and daily timeframes, with the MACD and Bollinger Bands supporting the upward trend. However, monthly RSI and MACD suggested some caution, indicating potential short-term consolidation after the strong rally. The stock’s resilience amid a broadly bearish market environment highlighted its relative strength within the Pharmaceuticals & Biotechnology sector.
Why settle for Strides Pharma Science Ltd? SwitchER evaluates this small-cap against peers, other sectors, and market caps to find you superior investment opportunities!
- - Comprehensive evaluation done
- - Superior opportunities identified
- - Smart switching enabled
Daily Price Comparison: Strides Pharma Science Ltd vs Sensex
| Date | Stock Price | Day Change | Sensex | Day Change |
|---|---|---|---|---|
| 2026-04-20 | Rs.995.90 | -0.48% | 35,814.68 | -0.02% |
| 2026-04-21 | Rs.997.65 | +0.18% | 36,091.30 | +0.77% |
| 2026-04-22 | Rs.1,001.80 | +0.42% | 36,009.59 | -0.23% |
| 2026-04-23 | Rs.1,070.90 | +6.90% | 35,729.71 | -0.78% |
| 2026-04-24 | Rs.1,068.05 | -0.27% | 35,349.66 | -1.06% |
Key Takeaways
Positive Signals: Strides Pharma Science Ltd demonstrated robust price appreciation of 6.73% for the week, significantly outperforming the Sensex’s 1.31% decline. The stock’s ability to hit multiple 52-week highs and maintain trading above all major moving averages reflects strong technical momentum and investor interest. The upgrade in Mojo Grade to Hold and inclusion in the MomentumNow thematic list further support the stock’s improving fundamentals and market positioning.
Cautionary Notes: Despite the strong weekly gains, monthly technical indicators such as RSI and MACD suggest some caution, indicating potential short-term consolidation or volatility ahead. The broader market remains bearish, with the Sensex trading below key moving averages, which could weigh on sentiment. The stock’s classification as a small-cap also implies higher volatility compared to large-cap peers.
Conclusion
Strides Pharma Science Ltd’s performance in the week ending 24 April 2026 highlights a compelling rally driven by strong technical signals, milestone price achievements, and relative strength within a challenging market environment. The stock’s 6.73% weekly gain, supported by multiple new 52-week highs and positive momentum indicators, underscores its resilience amid a broadly declining Sensex. While some caution is warranted given mixed monthly signals and market headwinds, Strides Pharma’s sustained upward trajectory and improved rating reflect a noteworthy phase of strength in the Pharmaceuticals & Biotechnology sector.
Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Start Today
